BIOMAT Database Logo BIOMAT Database Logo

Dipeptide mimics. Conformationally restricted inhibitors of angiotensin-converting enzyme. 1983

E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Design of conformationally constrained angiotensin-converting enzyme inhibitors.
November 1984, Biochemical and biophysical research communications,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
[Synthesis and analysis of conformationally restricted analogs of peptide inhibitors of the angiotensin-converting enzyme].
January 1986, Bioorganicheskaia khimiia,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Dipeptide inhibitors of thermolysin and angiotensin I-converting enzyme.
January 2012, Current topics in medicinal chemistry,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Dipeptide-hydroxamates are good inhibitors of the angiotensin I-converting enzyme.
October 1983, Biochemical and biophysical research communications,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
March 1991, Journal of medicinal chemistry,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Angiotensin converting enzyme inhibitors.
April 1990, American journal of hypertension,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
[Angiotensin converting enzyme inhibitors].
January 1995, Journal de pharmacie de Belgique,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Angiotensin-converting enzyme inhibitors.
September 1987, The Medical clinics of North America,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
Angiotensin-converting enzyme inhibitors.
May 1992, AACN clinical issues in critical care nursing,
E D Thorsett, and E E Harris, and S Aster, and E R Peterson, and D Taub, and A A Patchett, and E H Ulm, and T C Vassil
[Angiotensin converting enzyme inhibitors].
July 2006, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Copied contents to your clipboard!